“…Enhanced activity of G6PDH, a lipogenic enzyme, was found at diabetes and obesity (Gupte, 2010). In humans, G6PDH is regulated by many transcription factors, in particular, SREBP-1a (sterol regulatory element binding protein) (Amemiya-Kudo et al, 2002), AP-1 (Kletzien et al, 1994) and Sp1 (Franzè et al, 1998). It was shown that elevation of G6PDH activity might lead to enhanced lipid synthesis (Salati et al, 2001;Park et al, 2005;Lee et al, 2011) and to possible reductive stress (Dimmeler & Zeiher, 2007;Rajasekaran et al, 2007;Ralser & Benjamin, 2008).…”